BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 1864220)

  • 1. Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension.
    Modan M; Halkin H
    Diabetes Care; 1991 Jun; 14(6):470-87. PubMed ID: 1864220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, energy balance and sympathetic nervous system activity.
    Landsberg L
    Clin Exp Hypertens A; 1990; 12(5):817-30. PubMed ID: 2208753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium and obesity in the pathogenesis of hypertension.
    Reisin E
    Am J Hypertens; 1990 Feb; 3(2):164-7. PubMed ID: 2155002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations?
    Hall JE; Brands MW; Zappe DH; Alonso Galicia M
    Proc Soc Exp Biol Med; 1995 Apr; 208(4):317-29. PubMed ID: 7700881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and hypertension: roles of hyperinsulinemia, sympathetic nervous system and intrarenal mechanisms.
    Brands MW; Hall JE; Van Vliet BN; Alonso-Galicia M; Herrera GA; Zappe D
    J Nutr; 1995 Jun; 125(6 Suppl):1725S-1731S. PubMed ID: 7782935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, hyperinsulinemia and hypertension.
    Weidmann P; de Courten M; Böhlen L
    J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, metabolism, and hypertension.
    Landsberg L
    Yale J Biol Med; 1989; 62(5):511-9. PubMed ID: 2697985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.
    da Silva AA; do Carmo JM; Li X; Wang Z; Mouton AJ; Hall JE
    Can J Cardiol; 2020 May; 36(5):671-682. PubMed ID: 32389340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinemia: possible role in obesity-induced hypertension.
    Landsberg L
    Hypertension; 1992 Jan; 19(1 Suppl):I61-6. PubMed ID: 1730456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).
    Landsberg L
    J Hypertens; 2001 Mar; 19(3 Pt 2):523-8. PubMed ID: 11327624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and hyperinsulinemia in hypertension.
    Weidmann P; Böhlen L; de Courten M
    J Hypertens Suppl; 1995 Aug; 13(2):S65-72. PubMed ID: 8576790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and the sympathetic nervous system in the pathophysiology of hypertension.
    Landsberg L
    Blood Press Suppl; 1996; 1():25-9. PubMed ID: 9162434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia.
    Flack JM; Sowers JR
    Am J Med; 1991 Jul; 91(1A):11S-21S. PubMed ID: 1867224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Karapanagiotidis S; Wong C; Richards K; Marusic P; Dixon JB; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1701-7. PubMed ID: 24937541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
    DeFronzo RA; Ferrannini E
    Diabetes Care; 1991 Mar; 14(3):173-94. PubMed ID: 2044434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance.
    de Jongh RT; Serné EH; IJzerman RG; de Vries G; Stehouwer CD
    Circulation; 2004 Jun; 109(21):2529-35. PubMed ID: 15136505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms in obesity-related hypertension: role of insulin and catecholamines.
    Krieger DR; Landsberg L
    Am J Hypertens; 1988 Jan; 1(1):84-90. PubMed ID: 3285861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome.
    Landsberg L
    Ann N Y Acad Sci; 1999 Nov; 892():84-90. PubMed ID: 10842654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
    Modan M; Halkin H; Almog S; Lusky A; Eshkol A; Shefi M; Shitrit A; Fuchs Z
    J Clin Invest; 1985 Mar; 75(3):809-17. PubMed ID: 3884667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.